Literature DB >> 17932842

A comparison of the polypropylene plate Ahmed glaucoma valve to the silicone plate Ahmed glaucoma flexible valve.

D M Hinkle1, D Zurakowski, R S Ayyala.   

Abstract

PURPOSE: To compare surgical outcomes following implantation of the polypropylene plate Ahmed glaucoma valve (AGV) (S-2) and the newer silicone plate AGV (FP-7) with minimum 12 months follow-up in patients with intractable glaucoma.
DESIGN: Retrospective chart review of 25 eyes of 22 patients who underwent FP-7 and 26 eyes of 22 patients who underwent S-2 AGV implantation by a single surgeon. Main outcome measures included surgical outcomes in terms of intraocular pressure (IOP) control, hypertensive phase, and postoperative complications.
RESULTS: There were no significant differences in diagnoses, pre-and postoperative IOP, pre- and postoperative visual acuities at all time points, and in the number of pre- and postoperative medications between the groups. Significant IOP reductions occurred after FP-7 implantation (29.6 +/- 13.1 to 12.1 +/- 3.4, p < 0.001) and S-2 implantation (31.4 +/- 11.7 to 16.1 +/- 5.7, p < 0.001). The FP-7 group had a statistically lower IOP compared to the S-2 group at 6 (p<0.05), 9 (p<0.01), and 12 months (p<0.01). There was no significant difference in the hypertensive phase between the two groups (p=0.41).
CONCLUSIONS: FP-7 model silicone plate AGV resulted in lower IOP compared to the older S-2 polypropylene plate AGV at 1 year. This may suggest that the plate material may influence clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932842     DOI: 10.1177/112067210701700502

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  17 in total

1.  Can topical ketorolac 0.5% improve the function of Ahmed® glaucoma drainage devices?

Authors:  Garrett R Scott; Jennifer S Weizer; Sayoko E Moroi; Christina A Bruno; David C Musch; Leslie M Niziol; Paul P Lee; Joshua D Stein
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-03-31

2.  Assessing risk factors for postoperative hypotony in Ahmed glaucoma valve implantation surgery.

Authors:  Ahmet Kaderli; Gülizar Demirok; Güner Üney; Mehmet Yakın; Berku Günal; Ümit Ekşioğlu
Journal:  Int Ophthalmol       Date:  2021-05-21       Impact factor: 2.031

3.  [Pathophysiology of fibrotic encapsulation of episcleral glaucoma drainage implants: modification for improvement of clinical results].

Authors:  L Choritz; M Wegner; R Förch; U Jonas; H Thieme
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

4.  The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).

Authors:  Peter A Netland
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

Review 5.  Current status of epibulbar anti-glaucoma drainage devices in glaucoma surgery.

Authors:  Hagen Thieme
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

Review 6.  [Glaucoma drainage devices].

Authors:  H Thieme
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

7.  [Tube versus trabeculectomy study].

Authors:  H Thieme; L Choritz; C Schuart; T Wecke
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

8.  Risk factors for hypertensive phase after Ahmed glaucoma valve implantation.

Authors:  Onur Özalp; Serdar İlgüy; Eray Atalay; Tülay Şimşek; Nilgün Yıldırım
Journal:  Int Ophthalmol       Date:  2021-08-22       Impact factor: 2.031

9.  Application of 5-Fluorouracil-Polycaprolactone Sustained-Release Film in Ahmed Glaucoma Valve Implantation Inhibits Postoperative Bleb Scarring in Rabbit Eyes.

Authors:  Xiu-Zeng Bi; Wei-Hua Pan; Xin-Ping Yu; Zong-Ming Song; Zeng-Jin Ren; Min Sun; Cong-Hui Li; Kai-Hui Nan
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

10.  Comparison of the outcome of silicone Ahmed glaucoma valve implantation with a surface area between 96 and 184 mm² in adult eyes.

Authors:  Kyung Min Koh; Young Hoon Hwang; Jong Jin Jung; Yong Ho Sohn; Hwang Ki Kim
Journal:  Korean J Ophthalmol       Date:  2013-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.